New hope for women with Tough-to-Treat cervical cancer
NCT ID NCT07392060
Summary
This study is testing whether a new two-drug combination (WX390 plus toripalimab) works better than standard treatments for women with advanced cervical cancer that has returned or spread and has stopped responding to prior platinum-based chemotherapy. It will involve about 440 participants and directly compare how long patients live on the new combination versus currently available therapies. The goal is to control the cancer and extend survival for those with limited treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER METASTATIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.